300 related articles for article (PubMed ID: 8730124)
1. Inorganic pyrophosphate generation from adenosine triphosphate by cell-free human synovial fluid.
Park W; Masuda I; Cardenal-Escarcena A; Palmer DL; McCarty DJ
J Rheumatol; 1996 Apr; 23(4):665-71. PubMed ID: 8730124
[TBL] [Abstract][Full Text] [Related]
2. Inorganic pyrophosphate pool size and turnover rate in arthritic joints.
Camerlain M; McCarty DJ; Silcox DC; Jung A
J Clin Invest; 1975 Jun; 55(6):1373-81. PubMed ID: 166095
[TBL] [Abstract][Full Text] [Related]
3. Generation of inorganic pyrophosphate from extracellular adenosine triphosphate by human serum and plasma.
Park W; Masuda I; Cardenal-Escarcena A; Palmer DW; McCarty DJ
J Rheumatol; 1996 Jul; 23(7):1233-6. PubMed ID: 8823698
[TBL] [Abstract][Full Text] [Related]
4. Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate.
Ryan LM; Rachow JW; McCarty DJ
J Rheumatol; 1991 May; 18(5):716-20. PubMed ID: 1650841
[TBL] [Abstract][Full Text] [Related]
5. Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints.
Pattrick M; Hamilton E; Hornby J; Doherty M
Ann Rheum Dis; 1991 Apr; 50(4):214-8. PubMed ID: 1851409
[TBL] [Abstract][Full Text] [Related]
6. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
7. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.
Hirose J; Ryan LM; Masuda I
Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726
[TBL] [Abstract][Full Text] [Related]
8. Citrate in synovial fluid and its relation to inflammation and crystal presence.
Van Linthoudt D; Salani I; Zender R; Locatelli P; Ott H; Schumacher HR
J Rheumatol; 1996 Mar; 23(3):502-5. PubMed ID: 8832992
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting the solubility of calcium pyrophosphate dihydrate crystals.
Bennett RM; Lehr JR; McCarty DJ
J Clin Invest; 1975 Dec; 56(6):1571-9. PubMed ID: 423
[TBL] [Abstract][Full Text] [Related]
10. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H
J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616
[TBL] [Abstract][Full Text] [Related]
11. Synovial fluid inorganic pyrophosphate concentration and nucleotide pyrophosphohydrolase activity in basic calcium phosphate deposition arthropathy and Milwaukee shoulder syndrome.
Rachow JW; Ryan LM; McCarty DJ; Halverson PC
Arthritis Rheum; 1988 Mar; 31(3):408-13. PubMed ID: 2833903
[TBL] [Abstract][Full Text] [Related]
12. Correlation of changes in pain intensity with synovial fluid adenosine triphosphate levels after treatment of patients with osteoarthritis of the knee with high-molecular-weight hyaluronic acid.
Kumahashi N; Naitou K; Nishi H; Oae K; Watanabe Y; Kuwata S; Ochi M; Ikeda M; Uchio Y
Knee; 2011 Jun; 18(3):160-4. PubMed ID: 20627733
[TBL] [Abstract][Full Text] [Related]
13. Soluble E-selectin is increased in inflammatory synovial fluid.
Carson CW; Beall LD; Hunder GG; Johnson CM; Newman W
J Rheumatol; 1994 Apr; 21(4):605-11. PubMed ID: 7518520
[TBL] [Abstract][Full Text] [Related]
14. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis.
Castagnetta LA; Carruba G; Granata OM; Stefano R; Miele M; Schmidt M; Cutolo M; Straub RH
J Rheumatol; 2003 Dec; 30(12):2597-605. PubMed ID: 14719200
[TBL] [Abstract][Full Text] [Related]
15. Inorganic pyrophosphate metabolism in arthritis.
Rachow JW; Ryan LM
Rheum Dis Clin North Am; 1988 Aug; 14(2):289-302. PubMed ID: 2845490
[TBL] [Abstract][Full Text] [Related]
16. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
[TBL] [Abstract][Full Text] [Related]
17. [Alizarin red S staining of calcium compound crystals in synovial fluid].
Shoji K
Nihon Seikeigeka Gakkai Zasshi; 1993 Apr; 67(4):201-10. PubMed ID: 7686572
[TBL] [Abstract][Full Text] [Related]
18. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
19. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis.
Menkes CJ; Renoux M; Laoussadi S; Mauborgne A; Bruxelle J; Cesselin F
J Rheumatol; 1993 Apr; 20(4):714-7. PubMed ID: 7684449
[TBL] [Abstract][Full Text] [Related]
20. Association between synovial fluid levels of inorganic pyrophosphate and short term radiographic outcome of knee osteoarthritis.
Doherty M; Belcher C; Regan M; Jones A; Ledingham J
Ann Rheum Dis; 1996 Jul; 55(7):432-6. PubMed ID: 8774160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
